Ionolyte

Magnesium chloride hexahydrate, potassium chloride, sodium chloride and sodium acetate trihydrate, the active ingredients in Ionolyte, are an electrolyte solution presented as an intravenous solution for intravenous use. It restores extracellular fluid volume and corrects electrolyte imbalances in patients undergoing fluid resuscitation, surgery, or experiencing dehydration and electrolyte loss. It is indicated for adult and pediatric patients when rapid correction of sodium, potassium, magnesium and acetate deficits is required, and may be used under physician supervision in intensive care settings.

GNH USA supplies Ionolyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ionolyte is used for fluid and electrolyte replacement in clinical situations that involve loss or imbalance of key electrolytes. - Electrolyte replacement: restores sodium, potassium, magnesium and acetate levels in patients with deficits. - Fluid resuscitation: expands intravascular volume in hypovolemic patients. - Surgical peri‑operative care: maintains electrolyte balance during major operations. - Critical care: supports patients with severe electrolyte disturbances in intensive care units.

Ionolyte may be associated with adverse reactions typical of intravenous electrolyte solutions.

Common Side Effects: - Injection site irritation: pain, redness or swelling at the infusion site. - Electrolyte overshoot: transient hypernatremia, hyperkalemia, or hypermagnesemia. - Metabolic alkalosis: due to acetate conversion to bicarbonate. - Hypotension: mild drop in blood pressure during rapid infusion. - Fluid overload: signs of pulmonary edema in susceptible patients.

Serious or Rare Side Effects: - Severe hyperkalemia: can cause cardiac arrhythmias. - Severe hypermagnesemia: may lead to respiratory depression. - Anaphylactic reaction: rare hypersensitivity to solution components.

When using Ionolyte, clinicians should observe specific precautions to minimize risks. - Assess baseline electrolytes: obtain serum sodium, potassium, magnesium and acid‑base status before infusion. - Adjust infusion rate: avoid rapid administration to prevent fluid overload and electrolyte shifts. - Monitor cardiac rhythm: watch for arrhythmias especially in patients with renal impairment. - Renal function: reduce dose or increase monitoring in patients with decreased kidney clearance. - Pregnancy and lactation: use only if clearly indicated and benefits outweigh potential risks. - Store at ambient temperature: keep below 25°C, protect from moisture and light, and use within the labeled expiry.

Ionolyte can interact with other medications that affect electrolyte balance or cardiac conduction.

Major Interactions (Avoid): - Potassium‑sparing diuretics: may cause dangerous hyperkalemia when combined. - Magnesium‑containing laxatives or antacids: increase risk of hypermagnesemia. - Calcium channel blockers: additive effects on cardiac conduction with electrolyte shifts.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor potassium levels closely. - Loop diuretics: may require adjustment of electrolyte supplementation. - Insulin therapy: insulin drives potassium into cells, increasing risk of hypokalemia after infusion.